About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Borderzone Sampling

Borderzone Sampling

NCT00780819·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Maastricht University Medical Center

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

supratentorial brain tumor, on contrast enhanced MRI suspect for a high grade glioma
indication for resection of the tumor
age ≥ 18 years
WHO Performance Scale ≤ 2
ASA class ≤ 3
good knowledge of the Dutch language
informed consent

You may not be if

recurrent tumor
multiple tumor localizations
prior radiotherapy on the skull
prior chemotherapy

The record

StatusCompleted

PhaseNo phase

Taking part10

StartedOct 2008

UpdatedMay 14, 2013

Conditions

High Grade Glioma Glioblastoma

Where1

Maastricht University Medical Center
Maastricht, Limburg, Netherlands